Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Pollen and spore monitoring in the world.

Buters JTM, Antunes C, Galveias A, Bergmann KC, Thibaudon M, Galán C, Schmidt-Weber C, Oteros J.

Clin Transl Allergy. 2018 Apr 4;8:9. doi: 10.1186/s13601-018-0197-8. eCollection 2018.

2.

Cytochrome P450s in human immune cells regulate IL-22 and c-Kit via an AHR feedback loop.

Effner R, Hiller J, Eyerich S, Traidl-Hoffmann C, Brockow K, Triggiani M, Behrendt H, Schmidt-Weber CB, Buters JT.

Sci Rep. 2017 Mar 9;7:44005. doi: 10.1038/srep44005.

3.

First comparison of symptom data with allergen content (Bet v 1 and Phl p 5 measurements) and pollen data from four European regions during 2009-2011.

Bastl K, Kmenta M, Pessi AM, Prank M, Saarto A, Sofiev M, Bergmann KC, Buters JTM, Thibaudon M, Jäger S, Berger U.

Sci Total Environ. 2016 Apr 1;548-549:229-235. doi: 10.1016/j.scitotenv.2016.01.014. Epub 2016 Jan 21.

PMID:
26802351
4.

Automatic and Online Pollen Monitoring.

Oteros J, Pusch G, Weichenmeier I, Heimann U, Möller R, Röseler S, Traidl-Hoffmann C, Schmidt-Weber C, Buters JT.

Int Arch Allergy Immunol. 2015;167(3):158-66. doi: 10.1159/000436968. Epub 2015 Aug 19.

5.

Pollen-derived nonallergenic substances enhance Th2-induced IgE production in B cells.

Oeder S, Alessandrini F, Wirz OF, Braun A, Wimmer M, Frank U, Hauser M, Durner J, Ferreira F, Ernst D, Mempel M, Gilles S, Buters JT, Behrendt H, Traidl-Hoffmann C, Schmidt-Weber C, Akdis M, Gutermuth J.

Allergy. 2015 Nov;70(11):1450-60. doi: 10.1111/all.12707. Epub 2015 Aug 28.

PMID:
26214762
6.

Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization.

D'Amato G, Holgate ST, Pawankar R, Ledford DK, Cecchi L, Al-Ahmad M, Al-Enezi F, Al-Muhsen S, Ansotegui I, Baena-Cagnani CE, Baker DJ, Bayram H, Bergmann KC, Boulet LP, Buters JT, D'Amato M, Dorsano S, Douwes J, Finlay SE, Garrasi D, Gómez M, Haahtela T, Halwani R, Hassani Y, Mahboub B, Marks G, Michelozzi P, Montagni M, Nunes C, Oh JJ, Popov TA, Portnoy J, Ridolo E, Rosário N, Rottem M, Sánchez-Borges M, Sibanda E, Sienra-Monge JJ, Vitale C, Annesi-Maesano I.

World Allergy Organ J. 2015 Jul 14;8(1):25. doi: 10.1186/s40413-015-0073-0. eCollection 2015.

7.

Particulate matter from both heavy fuel oil and diesel fuel shipping emissions show strong biological effects on human lung cells at realistic and comparable in vitro exposure conditions.

Oeder S, Kanashova T, Sippula O, Sapcariu SC, Streibel T, Arteaga-Salas JM, Passig J, Dilger M, Paur HR, Schlager C, Mülhopt S, Diabaté S, Weiss C, Stengel B, Rabe R, Harndorf H, Torvela T, Jokiniemi JK, Hirvonen MR, Schmidt-Weber C, Traidl-Hoffmann C, BéruBé KA, Wlodarczyk AJ, Prytherch Z, Michalke B, Krebs T, Prévôt AS, Kelbg M, Tiggesbäumker J, Karg E, Jakobi G, Scholtes S, Schnelle-Kreis J, Lintelmann J, Matuschek G, Sklorz M, Klingbeil S, Orasche J, Richthammer P, Müller L, Elsasser M, Reda A, Gröger T, Weggler B, Schwemer T, Czech H, Rüger CP, Abbaszade G, Radischat C, Hiller K, Buters JT, Dittmar G, Zimmermann R.

PLoS One. 2015 Jun 3;10(6):e0126536. doi: 10.1371/journal.pone.0126536. eCollection 2015.

8.

High environmental ozone levels lead to enhanced allergenicity of birch pollen.

Beck I, Jochner S, Gilles S, McIntyre M, Buters JT, Schmidt-Weber C, Behrendt H, Ring J, Menzel A, Traidl-Hoffmann C.

PLoS One. 2013 Nov 20;8(11):e80147. doi: 10.1371/journal.pone.0080147. eCollection 2013.

9.

Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1.

Galan C, Antunes C, Brandao R, Torres C, Garcia-Mozo H, Caeiro E, Ferro R, Prank M, Sofiev M, Albertini R, Berger U, Cecchi L, Celenk S, Grewling Ł, Jackowiak B, Jäger S, Kennedy R, Rantio-Lehtimäki A, Reese G, Sauliene I, Smith M, Thibaudon M, Weber B, Weichenmeier I, Pusch G, Buters JT; HIALINE working group.

Allergy. 2013 Jun;68(6):809-12. doi: 10.1111/all.12144. Epub 2013 May 6.

PMID:
23647633
10.

Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine.

Peters LM, Demmel S, Pusch G, Buters JT, Thormann W, Zielinski J, Leeb T, Mevissen M, Schmitz A.

Toxicol Appl Pharmacol. 2013 Jan 1;266(1):101-8. doi: 10.1016/j.taap.2012.10.028. Epub 2012 Nov 7.

PMID:
23142468
11.

Airborne indoor particles from schools are more toxic than outdoor particles.

Oeder S, Jörres RA, Weichenmeier I, Pusch G, Schober W, Pfab F, Behrendt H, Schierl R, Kronseder A, Nowak D, Dietrich S, Fernández-Caldas E, Lintelmann J, Zimmermann R, Lang R, Mages J, Fromme H, Buters JT.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):575-82. doi: 10.1165/rcmb.2012-0139OC. Epub 2012 Aug 16.

PMID:
22904196
12.

GSTM1, GSTT1 and GSTP1 gene polymorphism in polymorphous light eruption.

Zirbs M, Pürner C, Buters JT, Effner R, Weidinger S, Ring J, Eberlein B.

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):157-62. doi: 10.1111/j.1468-3083.2011.04431.x. Epub 2012 Jan 9.

PMID:
22225519
13.

Toxicity and elemental composition of particulate matter from outdoor and indoor air of elementary schools in Munich, Germany.

Oeder S, Dietrich S, Weichenmeier I, Schober W, Pusch G, Jörres RA, Schierl R, Nowak D, Fromme H, Behrendt H, Buters JT.

Indoor Air. 2012 Apr;22(2):148-58. doi: 10.1111/j.1600-0668.2011.00743.x. Epub 2011 Oct 24.

PMID:
21913995
14.

rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.

Roedl D, Oji V, Buters JT, Behrendt H, Braun-Falco M.

J Dermatol Sci. 2011 Mar;61(3):194-8. doi: 10.1016/j.jdermsci.2010.12.004. Epub 2010 Dec 21.

PMID:
21251800
15.

The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts.

Buters JT, Weichenmeier I, Ochs S, Pusch G, Kreyling W, Boere AJ, Schober W, Behrendt H.

Allergy. 2010 Jul;65(7):850-8. doi: 10.1111/j.1398-9995.2009.02286.x. Epub 2010 Feb 4.

PMID:
20132158
16.

[Lead intoxication in a group of workers in Germany].

Willi RF, Felgenhauer N, Eyer F, Buters JT, Zilker T.

Dtsch Med Wochenschr. 2009 Dec;134(50):2556-60. doi: 10.1055/s-0029-1243060. Epub 2009 Dec 8. German.

PMID:
19998225
17.

Differential impact of diesel particle composition on pro-allergic dendritic cell function.

Braun A, Bewersdorff M, Lintelmann J, Matuschek G, Jakob T, Göttlicher M, Schober W, Buters JT, Behrendt H, Mempel M.

Toxicol Sci. 2010 Jan;113(1):85-94. doi: 10.1093/toxsci/kfp239. Epub 2009 Oct 4.

PMID:
19805405
18.

Metabolic activation of phenanthrene by human and mouse cytochromes P450 and pharmacokinetics in CYP1A2 knockout mice.

Schober W, Pusch G, Oeder S, Reindl H, Behrendt H, Buters JT.

Chem Biol Interact. 2010 Jan 5;183(1):57-66. doi: 10.1016/j.cbi.2009.09.008.

PMID:
19766613
19.

Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE-independent mast cell degranulation elicited by neuromuscular blocking agents.

Chen W, Beck I, Schober W, Brockow K, Effner R, Buters JT, Behrendt H, Ring J.

Exp Dermatol. 2010 Mar;19(3):302-4. doi: 10.1111/j.1600-0625.2009.00969.x. Epub 2009 Sep 16.

PMID:
19758318
20.

Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils.

Lubitz S, Schober W, Pusch G, Effner R, Klopp N, Behrendt H, Buters JT.

Environ Toxicol. 2010 Apr;25(2):188-97. doi: 10.1002/tox.20490.

PMID:
19382185
21.

Contact anaphylaxis and protein contact dermatitis in a cook handling chicory leaves.

Willi R, Pfab F, Huss-Marp J, Buters JT, Zilker T, Behrendt H, Ring J, Darsow U.

Contact Dermatitis. 2009 Apr;60(4):226-7. doi: 10.1111/j.1600-0536.2008.01461.x. No abstract available.

PMID:
19338594
22.

Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.

Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D.

Mutat Res. 2008 Mar 1;639(1-2):11-9. Epub 2007 Nov 5.

PMID:
18067928
23.

Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between West and South Germany.

Buters JT, Kasche A, Weichenmeier I, Schober W, Klaus S, Traidl-Hoffmann C, Menzel A, Huss-Marp J, Kramer U, Behrendt H.

Int Arch Allergy Immunol. 2008;145(2):122-30. Epub 2007 Sep 10.

PMID:
17848805
24.

Toxicity of parked motor vehicle indoor air.

Buters JT, Schober W, Gutermuth J, Jakob T, Aguilar-Pimentel A, Huss-Marp J, Traidl-Hoffmann C, Mair S, Mair S, Mayer F, Breuer K, Behrendt H.

Environ Sci Technol. 2007 Apr 1;41(7):2622-9.

PMID:
17438825
25.

Effective strategies for tumors affecting chemopreventive metabolism.

Buters JT.

Clin Cancer Res. 2006 Dec 15;12(24):7203-4. No abstract available.

26.

Identification of 2,3-epoxymethacrylic acid as an intermediate in the metabolism of dental materials in human liver microsomes.

Seiss M, Nitz S, Kleinsasser N, Buters JT, Behrendt H, Hickel R, Reichl FX.

Dent Mater. 2007 Jan;23(1):9-16. Epub 2006 Feb 2.

PMID:
16458349
27.

Importance of NO/cGMP signalling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol.

Werner C, Raivich G, Cowen M, Strekalova T, Sillaber I, Buters JT, Spanagel R, Hofmann F.

Eur J Neurosci. 2004 Dec;20(12):3498-506.

PMID:
15610182
28.

Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.

Buters JT, Mahadevan B, Quintanilla-Martinez L, Gonzalez FJ, Greim H, Baird WM, Luch A.

Chem Res Toxicol. 2002 Sep;15(9):1127-35.

PMID:
12230405
29.

Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.

Krausz KW, Goldfarb I, Buters JT, Yang TJ, Gonzalez FJ, Gelboin HV.

Drug Metab Dispos. 2001 Nov;29(11):1410-23.

30.

Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene.

Heidel SM, MacWilliams PS, Baird WM, Dashwood WM, Buters JT, Gonzalez FJ, Larsen MC, Czuprynski CJ, Jefcoate CR.

Cancer Res. 2000 Jul 1;60(13):3454-60.

31.

Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene.

Heidel SM, Holston K, Buters JT, Gonzalez FJ, Jefcoate CR, Czupyrynski CJ.

Mol Pharmacol. 1999 Dec;56(6):1317-23.

32.

Cytochrome P450-null mice.

Buters JT, Doehmer J, Gonzalez FJ.

Drug Metab Rev. 1999 May;31(2):437-47. Review. No abstract available.

PMID:
10335446
33.

Molecular studies on the toxifying effects by genetically engineered cytochromes P450.

Doehmer J, Buters JT, Luch A, Soballa V, Baird WM, Morisson H, Stegeman JJ, Townsend AJ, Greenlee WF, Glatt HR, Seidel A, Jacob J, Greim H.

Drug Metab Rev. 1999 May;31(2):423-35. Review. No abstract available.

PMID:
10335445
34.

Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1977-82.

35.

Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.

Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, Gonzalez FJ.

Toxicol Appl Pharmacol. 1998 Sep;152(1):193-9.

PMID:
9772215
36.

Inhibitory monoclonal antibody to human cytochrome P450 2B6.

Yang TJ, Krausz KW, Shou M, Yang SK, Buters JT, Gonzalez FJ, Gelboin HV.

Biochem Pharmacol. 1998 May 15;55(10):1633-40.

PMID:
9633999
37.

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.

Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T, Poruchynsky MS.

J Biol Chem. 1997 Jul 4;272(27):17118-25.

38.

Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system.

Chen L, Buters JT, Hardwick JP, Tamura S, Penman BW, Gonzalez FJ, Crespi CL.

Drug Metab Dispos. 1997 Apr;25(4):399-405.

39.

Differential mechanisms of cytochrome P450 inhibition and activation by alpha-naphthoflavone.

Koley AP, Buters JT, Robinson RC, Markowitz A, Friedman FK.

J Biol Chem. 1997 Feb 7;272(6):3149-52.

40.

Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1A1: a CO flash photolysis study.

Koley AP, Buters JT, Robinson RC, Markowitz A, Friedman FK.

Arch Biochem Biophys. 1996 Dec 15;336(2):261-7.

PMID:
8954573
41.

Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.

Shou M, Korzekwa KR, Krausz KW, Buters JT, Grogan J, Goldfarb I, Hardwick JP, Gonzalez FJ, Gelboin HV.

Mol Carcinog. 1996 Dec;17(4):241-9.

PMID:
8989918
42.

Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

Bourdi M, Chen W, Peter RM, Martin JL, Buters JT, Nelson SD, Pohl LR.

Chem Res Toxicol. 1996 Oct-Nov;9(7):1159-66.

PMID:
8902272
43.

Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.

Buters JT, Tang BK, Pineau T, Gelboin HV, Kimura S, Gonzalez FJ.

Pharmacogenetics. 1996 Aug;6(4):291-6.

PMID:
8873215
44.

Role of CYP2E1 in the hepatotoxicity of acetaminophen.

Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ.

J Biol Chem. 1996 May 17;271(20):12063-7.

45.

Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4.

Gelboin HV, Krausz KW, Goldfarb I, Buters JT, Yang SK, Gonzalez FJ, Korzekwa KR, Shou M.

Biochem Pharmacol. 1995 Nov 27;50(11):1841-50.

PMID:
8615863
46.

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE.

Cell Growth Differ. 1995 Nov;6(11):1395-403.

47.

Cytochrome P450 2A1, 2E1, and 2C9 cDNA-expression by insect cells and partial purification using hydrophobic chromatography.

Grogan J, Shou M, Andrusiak EA, Tamura S, Buters JT, Gonzalez FJ, Korzekwa KR.

Biochem Pharmacol. 1995 Oct 26;50(9):1509-15.

PMID:
7503803
48.

Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374.

Crespi CL, Steimel DT, Penman BW, Korzekwa KR, Fernandez-Salguero P, Buters JT, Gelboin HV, Gonzalez FJ, Idle JR, Daly AK.

Pharmacogenetics. 1995 Aug;5(4):234-43.

PMID:
8528270
50.

CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers.

Koley AP, Buters JT, Robinson RC, Markowitz A, Friedman FK.

J Biol Chem. 1995 Mar 10;270(10):5014-8.

Supplemental Content

Loading ...
Support Center